BASHAN DROR (President & CEO) received a stock award from PROTALIX BIOTHERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/28/2022ACC: 0001104659-22-028157
DirectorOfficer· President & CEO
Since Jun 2019
+637.53K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
637.53K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+637.53K
Price / share
—
Trade value
—
% of position
142.3%
2/25/2022
447.93K→1.09M
Total
Net shares
+637.53K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/25/2022 | A · Award | +637.53K | — | — | 142.3% | 447.93K | 1.09M |
| Total | +637.53K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported